Life-Threatening Amlodipine Over Dose Requiring ECMO Support Treated by High-Cut-Off Dialysis and Cytosorb

Julius J Schmidt, M. Busch, S. David, W. N. K. Velten, M. Hoeper, Jan TKielstein
{"title":"Life-Threatening Amlodipine Over Dose Requiring ECMO Support Treated by High-Cut-Off Dialysis and Cytosorb","authors":"Julius J Schmidt, M. Busch, S. David, W. N. K. Velten, M. Hoeper, Jan TKielstein","doi":"10.35248/2161-0495.21.11.479","DOIUrl":null,"url":null,"abstract":"Calcium Channel Blockers (CCBs) may cause profound vasopressor resistant hypotension in case of intoxication. Recently, the EXTRIP workgroup recommended against the use of Extra Corporeal Treatment Modalities (ECTM) for the elimination of amlodipine. Anecdotal evidence suggests that Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) may be beneficial in patients with severe shock due to amlodipine intoxication. We report a case of severe amlodipine poisoning (total amlodipine intake 625 mg), in which we used awake-VA- ECMO support for hemodynamic stabilization. A combination of a HCO dialyzer and the Cytosorb® adsorber was used to eliminate amlodipine in two consecutive treatment sessions. Amlodipine dialyzer clearance and Cytosorb® adsorber clearance were 13.8 (-2,3–20.4) mL/min and 17.5 (9.6–25.6) mL/min, respectively. Clearance levels varied depending on drug plasma levels. During this treatment, initial amlodipine levels fell by 48% and 15% with a total eliminated amount of 242 and 352 μg of amlodipine, respectively, in the dialysate. EXTRIP criteria for dialyzability could not be met by the investigated modalities. ECMO therapy was discontinued after three days and the patient fully recovered. In conclusion, VA-ECMO support can be used for hemodynamic stabilization of patients with severe amlodipine poisoning, while the extracorporeal elimination techniques used in this setting were unable to remove a meaningful amount of drug.","PeriodicalId":15433,"journal":{"name":"Journal of Clinical Toxicology","volume":"11 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2161-0495.21.11.479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Calcium Channel Blockers (CCBs) may cause profound vasopressor resistant hypotension in case of intoxication. Recently, the EXTRIP workgroup recommended against the use of Extra Corporeal Treatment Modalities (ECTM) for the elimination of amlodipine. Anecdotal evidence suggests that Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) may be beneficial in patients with severe shock due to amlodipine intoxication. We report a case of severe amlodipine poisoning (total amlodipine intake 625 mg), in which we used awake-VA- ECMO support for hemodynamic stabilization. A combination of a HCO dialyzer and the Cytosorb® adsorber was used to eliminate amlodipine in two consecutive treatment sessions. Amlodipine dialyzer clearance and Cytosorb® adsorber clearance were 13.8 (-2,3–20.4) mL/min and 17.5 (9.6–25.6) mL/min, respectively. Clearance levels varied depending on drug plasma levels. During this treatment, initial amlodipine levels fell by 48% and 15% with a total eliminated amount of 242 and 352 μg of amlodipine, respectively, in the dialysate. EXTRIP criteria for dialyzability could not be met by the investigated modalities. ECMO therapy was discontinued after three days and the patient fully recovered. In conclusion, VA-ECMO support can be used for hemodynamic stabilization of patients with severe amlodipine poisoning, while the extracorporeal elimination techniques used in this setting were unable to remove a meaningful amount of drug.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高临界值透析和Cytosorb治疗危及生命的氨氯地平过量需要ECMO支持
钙通道阻滞剂(CCBs)在中毒的情况下可能引起深度抗利尿激素低血压。最近,EXTRIP工作组建议不要使用体外治疗方式(ECTM)来消除氨氯地平。轶事证据表明,静脉-动脉体外膜氧合(VA-ECMO)可能对氨氯地平中毒引起的严重休克患者有益。我们报告了一例严重氨氯地平中毒(氨氯地平总摄入量625mg),我们使用清醒- va - ECMO支持来稳定血液动力学。在连续两个疗程中,使用HCO透析器和Cytosorb®吸附剂的组合来消除氨氯地平。氨氯地平透析器清除率和Cytosorb®吸附剂清除率分别为13.8 (-2,3 - 20.4)mL/min和17.5 (9.6-25.6)mL/min。清除水平取决于药物血浆水平。在此治疗期间,氨氯地平的初始水平下降了48%和15%,透析液中氨氯地平的总消除量分别为242和352 μg。所研究的模式不能满足透析性的EXTRIP标准。三天后停止ECMO治疗,患者完全康复。综上所述,VA-ECMO支持可用于严重氨氯地平中毒患者的血流动力学稳定,而在这种情况下使用的体外清除技术无法清除大量药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Synergic Effects of Acupuncture and Clinical Lactulose Therapy on Opioid-Induced Constipation Subacute Cutaneous Lupus Secondary to Trastuzumab Emtasine Angelandrsquo;s Trumpet (Brugmansia suaveolens) Poisoning Presenting with Anticholinergic Toxidrome A Hydroxychloroquine-Related Acute Liver Failure Case and Review of the Literature In vitro Inactivation of SARS-Cov-2 by Povidone-Iodine In situ Gel FormingSolution
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1